Skip to content
OpenCapital
Get started

QuidelOrtho Corporation QDEL North America — R&D

Other segment segments

China
$700K-22.2%
Latin America
$500K+25.0%
EMEA
$400K-33.3%
JPAC
$300K-25.0%

Similar metrics at other companies

Aebi Schmidt Holding AG Common Stock logo
AEBINorth America — R&D
$1.63M+172%
SSD
SSDNorth America — Research And Development And Other Engineering Expense
$15.91M-9.1%
Zimmer Biomet Holdings logo
ZBHAmericas — Research And Development Expense Excluding Acquired In Process Cost
$71.9M+1.1%
Brady Corporation logo
BRCAmericas & Asia — R&D
$16.95M+27.3%
Watts Water Technologies, Inc. logo
WTSAmericas — Research And Development Expense
$15.4M+12.4%
TFX
TFXAmericas — Research and development expenses
$14.25M+21.0%

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-56.1%
Enterprise value$3.8B-22.0%
P/S0.3×-0.4×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%—

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept qdel:SegmentInformationResearchAndDevelopmentExpense.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's north america — r&d.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's north america — R&D?
QuidelOrtho Corporation (QDEL) reported north america — R&D of $400K in Q1 2026.
How has QuidelOrtho Corporation's north america — R&D changed year-over-year?
QuidelOrtho Corporation's north america — R&D decreased by 0.0% year-over-year, from $400K to $400K.
What is the long-term trend for QuidelOrtho Corporation's north america — R&D?
Over 3 years (2022 to 2025), QuidelOrtho Corporation's north america — R&D has grown at a 17.0% compound annual growth rate (CAGR), from $1M to $1.6M.
What does north america — R&D mean?
Represents the expenditures dedicated to the innovation, development, and improvement of diagnostic testing technologies within the North American segment. This investment is critical for maintaining long-term competitiveness and expanding the product portfolio.